Peptides and related drugs: a review of their absorption, metabolism, and excretion.

作者信息

Humphrey M J, Ringrose P S

出版信息

Drug Metab Rev. 1986;17(3-4):283-310. doi: 10.3109/03602538608998293.

DOI:10.3109/03602538608998293

PMID:3552541

Abstract

摘要

相似文献

Drug Metab Rev. 1986;17(3-4):283-310. doi: 10.3109/03602538608998293.

[The effect of interactions on absorption, distribution and excretion of drugs].

Verh Dtsch Ges Inn Med. 1977;83:1567-74.

[Effects of hepato-biliary diseases on drug metabolism (author's transl)].

Nouv Presse Med. 1977 Oct 22;6(35):3209-19.

Novel routes of drug metabolism. A survey.

Drug Metab Dispos. 1977 Jul-Aug;5(4):411-5.

Nutrient interaction with drugs and other xenobiotics.

J Am Diet Assoc. 1985 Mar;85(3):335-9.

[Drugs and the organism--introduction to pharmacokinetics and biotransformation].

Pharmazie. 1978 Feb-Mar;33(2-3):128-74.

[Influence of disease on the metabolism and effects of drugs in man].

Union Med Can. 1980 Dec;109(12):1718-22.

[The effect of cancer on drug metabolism and drug action].

Sem Hop. 1977 Dec 9;53(42):2399-401.

Biotransformation of drugs in human skin.

Drug Metab Dispos. 2009 Feb;37(2):247-53. doi: 10.1124/dmd.108.024794. Epub 2008 Nov 12.

Drug metabolism in patients with liver disease.

Adv Intern Med. 1987;32:379-405.

引用本文的文献

Tripeptides inhibit dual targets AChE and BACE-1: a computational study.

RSC Adv. 2025 Apr 22;15(16):12866-12875. doi: 10.1039/d5ra00709g. eCollection 2025 Apr 16.

pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications.

ACS Appl Bio Mater. 2022 May 3. doi: 10.1021/acsabm.2c00188.

The Current Status of Drug Discovery for the Oxytocin Receptor.

Methods Mol Biol. 2022;2384:153-174. doi: 10.1007/978-1-0716-1759-5_10.

Exploiting Knowledge on Structure-Activity Relationships for Designing Peptidomimetics of Endogenous Peptides.

Biomedicines. 2021 Jun 7;9(6):651. doi: 10.3390/biomedicines9060651.

Past, present, and future technologies for oral delivery of therapeutic proteins.

J Pharm Sci. 2008 Jul;97(7):2497-523. doi: 10.1002/jps.21183.

Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).

Br J Pharmacol. 2003 Feb;138(4):564-73. doi: 10.1038/sj.bjp.0705049.

Targeted prodrug design to optimize drug delivery.

AAPS PharmSci. 2000;2(1):E6. doi: 10.1208/ps020106.

Intestinal peptide transport systems and oral drug availability.

Pharm Res. 1999 Sep;16(9):1331-43. doi: 10.1023/a:1018982505021.

Oral controlled release technology for peptides: status and future prospects.

Pharm Res. 1996 Dec;13(12):1760-4. doi: 10.1023/a:1016008419367.

D-cycloserine transport in human intestinal epithelial (Caco-2) cells: mediation by a H(+)-coupled amino acid transporter.

Br J Pharmacol. 1995 Jul;115(5):761-6. doi: 10.1111/j.1476-5381.1995.tb14998.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验